Research Progress in Treatment of Chemical Liver Injury with Chinese Medicine Based on Metabolomics
10.13422/j.cnki.syfjx.20210716
- VernacularTitle:基于代谢组学的中药治疗化学性肝损伤研究进展
- Author:
Lin-jing WU
1
;
Xue-chun YU
1
;
Jia-qun KE
1
;
Si-yu DENG
1
;
Cong HU
1
;
Yin-hua XIONG
1
;
Xi-lan TANG
1
Author Information
1. Jiangxi Provincial Key Laboratory of Drug Design and Evaluation，School of Pharmacy， Jiangxi Science and Technology Normal University，Nanchang 330013，China
- Publication Type:Research Article
- Keywords:
metabolomics;
Chinese medicine;
liver protection;
chemical liver injury;
biomarker;
mechanism of action
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2021;27(12):202-215
- CountryChina
- Language:Chinese
-
Abstract:
Liver， as a critical organ of metabolism and detoxification， can be damaged by viral infection， drug abuse， and heavy drinking. Liver diseases pose a serious threat to people's health and life in China.At present， drug therapy has been primarily adopted clinically in the treatment of the liver injury.In-depth investigation of the mechanism of liver-protective drugs is of great significance to the prevention and treatment of clinical liver diseases.In recent years， with the development of the medical industry in China， an increasing number of studies have focused on the treatment of liver injury with Chinese medicine.Compared with western medicine， Chinese medicine is advantageous in few side effects and overall regulation， which plays a pivotal role in liver protection.However， its underlying mechanism in liver protection still needs to be further studied due to its complex compositions and diverse targets.Metabolomics， a new approach to studying the metabolic pathway of biological systems， provides integral and systematic views in the investigation of liver protection with Chinese medicine. By virtue of metabolomics， the mechanism of Chinese medicine in multi-target and multi-pathway liver protection can be analyzed comprehensively， and the corresponding biomarkers can also be screened out. The authors analyzed the studies of the treatment of chemical liver injury models induced by carbon tetrachloride （CCl4）， dimethylnitrosamine （DMN）， α-naphthyl isothiocyanate （ANIT）， and alcohol by Chinese medicinal compounds， single herbal medicines， and monomers of Chinese medicine based on metabolomics， and summarized the biomarkers and related metabolic pathways of Chinese medicine in the intervention of each type of liver injury， aiming at providing a reference for the further research and clinical application in the treatment of different types of liver injuries by Chinese medicine.
